Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma (Q83137573)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 April 2010
edit
Language Label Description Also known as
English
Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma
scientific article published on 01 April 2010

    Statements

    Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit